ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner

Cancer Science

Volumn 101, Issue 6, 2010, Pages 1374-1381

  Yang, Jaw Ji ^a   Lee, Yi Ju ^a   Hung, Hsin Hung ^a   Tseng, Wei Pu ^a   Tu, Chuan Chou ^b   Lee, Huei ^a   Wu, Wen Jun ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; ZIPPER STERILE ALPHA MOTIF KINASE GENE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MIDDLE AGED; PROTEIN KINASES; TRANSCRIPTION FACTOR AP-1;

EID: 77954156988     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01537.x     Document Type: Article

References (34)

1. Gallo KA, Johnson GL. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol 2002, 3:663-72.
2. Liu TC, Huang CJ, Chu YC. Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a lecuine-zipper and a sterile-alpha motif. Biochem Biophys Res Commun 2000, 274:811-6.
3. Gotoh I, Adachi M, Nishid E. Identification and characterization of a novel MAP kinase kinase kinase, MLTK. J Biol Chem 2001, 276:4276-86.
4. Shen YH, Godlewski J, Zhu J. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J Biol Chem 2003, 278:26715-21.
5. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4:E131-6.
6. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995, 270:16483-6.
7. Deng T, Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 1994, 371:171-5.
8. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996, 74:589-607.
9. Kim KY, Kim BC, Xu Z, Kim SJ. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor β-induced apoptosis in hepatoma cells. J Biol Chem 2004, 279:29478-84.
10. Hong HY, Kim BC. Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells. Biochem Biophys Res Commun 2007, 362:307-12.
11. Cho YY, Bode AM, Mizuno H, Choi BY, Choi HS, Dong Z. A novel role for mixed-lineage kinase-like mitogen-activated protein triple kinase a in neoplastic cell transformation and tumor development. Cancer Res 2004, 64:3855-64.
12. Yang JJ. Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest. Biochem Biophys Res Commun 2002, 297:105-10.
13. Health Statistics 2007, Republic of China, Department of Health, Executive Yuan
14. Johnson NL, Gardner AM, Diener KM. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 1996, 271:3229-37.
15. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998, 74:49-139.
16. Nah SS, Won HJ, Park HJ. Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21CIP1/P27KIP1 pathways. J Pineal Res 2009, 47:70-4.
17. öllinger R, Kogler P, Troppmair J. Bilirubin inhibits tumor cell growth via activation of ERK. Cell Cycle 2007, 6:3078-85.
18. Hung H. Dietary quercetin inhibits proliferation of lung carcinoma cells. Forum Nutr 2007, 60:146-57.
19. Li Z, Li J, Mo B. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol Toxicol 2008, 24:401-9.
20. Chang GC, Hsu SL, Tsai JR, Wu WJ, Chen CY, Sheu GT. Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol 2004, 502:169-83.
21. Linford NJ, Yang Y, Cook DG, Dorsa DM. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 2001, 299:67-75.
22. Sahu RP, Zhang R, Batra S, Shi Y, Srivastava SK. Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis 2009, 30:1744-53.
23. Tang D, Wu D, Hirao A. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002, 277:12710-7.
24. Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2000, 275:39435-43.
25. Yan Y, Spieker RS, Kim M, Stoeger SM, Cowan KH. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation. Oncogene 2005, 24:3285-96.
26. Chang CH, Yu FY, Wang LT, Lin YS, Liu BH. Activation of ERK and JNK signaling pathways by mycotoxin citrinin in human cells. Toxicol Appl Pharmacol 2009, 237:281-7.
27. Lee SE, Lim JW, Kim H. Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann N Y Acad Sci 2009, 1171:163-9.
28. Moon DO, Kim MO, Kang SH. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK. Biochem Pharmacol 2008, 76:312-21.
29. Xu C, Shen G, Yuan X. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 2006, 27:437-45.
30. Wang X, Mader MM, Toth JE. Complete inhibition of anisomycin and UV radiation but not cytokine induced JNK and p38 activation by an aryl-substituted dihydropyrrolopyrazole quinoline and mixed lineage kinase 7 small interfering RNA. J Biol Chem 2005, 280:19298-305.
31. Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 2000, 19:4011-21.
32. Hartkamp J, Troppmair J, Rapp UR. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. Cancer Res 1999, 59:2195-202.
33. Chadee DN, Kyriakis JM. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. Nat Cell Biol 2004, 6:770-6.
34. Vesely PW, Staber PB, Hoefler G, Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat Res 2009, 682:7-12.